SITAGLIVAC M 50/1000

SITAGLIVAC M 50/1000 Tablet is a combination of Sitagliptin (50 mg) and Metformin (1000 mg), specially formulated to manage Type 2 Diabetes Mellitus (T2DM). This dual-action therapy helps patients achieve better blood sugar control when diet, exercise, and single-drug therapy are not enough.

• Sitagliptin (a DPP-4 inhibitor) increases insulin release and lowers glucose production in the liver.

• Metformin improves insulin sensitivity and decreases glucose absorption in the intestine.

Together, they provide comprehensive glycemic control and help reduce the risk of long-term diabetes complications.

Key Benefits:

• Dual-action formula for effective Type 2 Diabetes management

• Improves both fasting and post-meal blood glucose levels

• Enhances insulin response naturally

• Helps in reducing the risk of complications like nerve damage, kidney problems, and heart disease

• Supports long-term blood sugar balance when combined with lifestyle modifications